Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer

Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer

US Patent 9789182 · Granted Oct 17, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PD-1 antibodies and uses thereof2025
Treatment of cancer2025
Treatment regimens using anti-NKG2A antibodies2024
Electrical device having heat dissipation structure using filler and manufacturi2024
Air-pocket prevention PCB, air-pocket prevention PCB module, electrical device i2023
Liquid-crystal medium2023
Neutralization of inhibitory pathways in lymphocytes2023
Hot dip plated steel sheet having excellent corrosion resistance and workability2023
Antibodies against MICA and/or MICB and uses thereof2022
Treatment of cancers using anti-NKG2A agents2022
Combination therapy for the treatment of cancer2021
Plated steel sheet having fine and even plating structure2021